Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.100
-0.200-1.77%
Volume:7.70M
Turnover:85.51M
Market Cap:28.50B
PE:17.62
High:11.350
Open:11.310
Low:11.020
Close:11.300
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:1.46
T/O Rate:0.30%
Dividend:0.21
Dividend Rate:1.86%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.59
PE(LYR):17.62
PS:2.80

Loading ...

Simcere Pharmaceutical Group (SEHK:2096) Stock Price Trails Margin Surge And DCF Gap

Simply Wall St.
·
Aug 21

Simcere Pharmaceutical Grants 795,000 RSUs Under 2021 Share Award Scheme

Reuters
·
Aug 21

Simcere Pharmaceutical Group's H1 Attributable Profit Rises 38%

MT Newswires Live
·
Aug 21

Simcere Pharmaceutical reshuffles joint company secretaries; wins three-year Listing Rules waiver

Bulletin Express
·
Aug 20

Simcere Pharma initiates up to RMB 1.00 billion share buyback, covering 10% of issued capital

Bulletin Express
·
Aug 20

Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis

Stock News
·
Aug 20

Simcere Pharma Appoints Zhu Da as Joint Company Secretary

Stock News
·
Aug 20

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Reuters
·
Aug 20

Simcere Pharmaceutical Posts HY Net Income Attributable of RMB 829 MLN

Reuters
·
Aug 20

Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities

Reuters
·
Aug 20

Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion

Reuters
·
Aug 20

Simcere Pharmaceutical - Share Repurchase Period from Aug 21, 2026 Until Next AGM or Earlier if Authority Revoked

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - to Repurchase Shares in Open Market up to Rmb1,000 Mln

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - DR. Zhou Will Serve as President

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million

THOMSON REUTERS
·
Aug 20

Simcere Pharma Surges Nearly 5% in Morning Trading as Huatai Retains Buy Rating

Deep News
·
Aug 20

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Stock News
·
Aug 20

Earning Preview: SIMCERE PHARMA this quarter’s revenue is expected to increase by 27%, and institutional views are bullish

Earnings Agent
·
Aug 13

Simcere Pharma Sets 20 Aug 2026 Board Meeting to Review 1H26 Results and Possible Interim Dividend

Bulletin Express
·
Aug 10